{"name":"Taro Pharmaceutical Industries","slug":"taro","ticker":"TARO","exchange":"NYSE","domain":"taro.com","description":"Taro Pharmaceutical Industries is a global generic pharmaceutical company focusing on dermatology and specialty pharmaceuticals. The company's top products include generic versions of branded dermatological medications. Taro operates in the US and internationally, with a significant presence in the US market. The company's products are marketed through a combination of direct sales and partnerships with other pharmaceutical companies.","hq":"Haifa Bay, Israel / Hawthorne, NY","founded":1958,"employees":"~1,500","ceo":"Uday Baldota","sector":"Dermatology Generics / Specialty Pharma","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"1.4B","metrics":{"revenue":680000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1977-01-01","label":"Topicort first approved","drug":"Topicort","drugSlug":"desoximetasone","type":"approval","sentiment":"positive"},{"date":"1982-01-01","label":"Ovide first approved","drug":"Ovide","drugSlug":"malathion","type":"approval","sentiment":"positive"},{"date":"2026-05-26","label":"Topicort patent expiry (Formulation)","drug":"Topicort","drugSlug":"desoximetasone","type":"patent_expiry","sentiment":"negative"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-09-01","label":"Topicort patent expiry (Formulation)","drug":"Topicort","drugSlug":"desoximetasone","type":"patent_expiry","sentiment":"negative"},{"date":"2025-06-01","label":"Triamcinolone Acetonide Cream USP, 0.1% patent cliff ($100.0M at risk)","drug":"Triamcinolone Acetonide Cream USP, 0.1%","type":"patent_expiry","sentiment":"negative"},{"date":"2027-06-01","label":"Clobetasol Propionate Cream, 0.05% patent cliff ($50.0M at risk)","drug":"Clobetasol Propionate Cream, 0.05%","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Topicort","genericName":"DESOXIMETASONE","slug":"desoximetasone","indication":"Atopic dermatitis","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ovide","genericName":"MALATHION","slug":"malathion","indication":"Pediculosis capitis","status":"marketed"}]}],"pipeline":[{"name":"Topicort","genericName":"DESOXIMETASONE","slug":"desoximetasone","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Atopic dermatitis","Contact dermatitis","Discoid lupus erythematosus","Eruption of skin","Granuloma annulare"],"catalyst":""},{"name":"Ovide","genericName":"MALATHION","slug":"malathion","phase":"marketed","mechanism":"Melatonin receptor type 1A","indications":["Pediculosis capitis"],"catalyst":""}],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Taro Pharmaceutical Industries Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Taro Pharmaceutical Industries reported its fourth quarter and full year 2023 financial results, with revenue of $1.4 billion and net income of $123.4 million.","drugName":"","sentiment":"neutral"},{"date":"2023-08-01","type":"deal","headline":"Taro Pharmaceutical Industries Announces Agreement to Acquire Certain Assets from Sandoz","summary":"Taro Pharmaceutical Industries announced an agreement to acquire certain assets from Sandoz, a division of Novartis.","drugName":"","sentiment":"neutral"},{"date":"2022-12-20","type":"regulatory","headline":"FDA Approves Taro's Generic Version of Triamcinolone Acetonide Cream USP, 0.1%","summary":"The US FDA approved Taro's generic version of Triamcinolone Acetonide Cream USP, 0.1%.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOT1BmSHk4RlQwc3VPV1plWHNzcU9ublZDNUpmLXRrT1d0Q1B3REE5VzRsUDlBZ3UtMDl1cVNaOWJJTGVfMC05YjhqU0JsdDg1NDEwRWZVUnpza2p0bWJuQ1FoLVNpRy11eDZ3cDBWZlRSZU9uV2taSzBqbFdzbmJrSmJEVXNpY2wzUVJycTM0VW5lUnliWUZaNGdjNGx6Y25U?oc=5","date":"2026-03-20","type":"pipeline","source":"Fast Company","summary":"Children's ibuprofen recalled nationwide after customer complaints of 'gel-like mass and black particles' - Fast Company","headline":"Children's ibuprofen recalled nationwide after customer complaints of 'gel-like mass and black particles'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBuM2dkVDZScnhwMDlobEpYbnpERWpzNVRMZ05GVlR0NnN4dHFNX1V2TmhNLVhQNjRXS0RrOF9xUkRBZ1ExMll6Vi1VVUtQVUliVmhSZU4xNVNnU2VaaHlsRXZ5SXJuRHZiRE5tU3c4b3pveDFrRTZ5YmFuQXNrSDDSAYQBQVVfeXFMTTRuZnp0cHMxUWh6M0xscnB4dWhkTEowbUZXSWlWek96cjg4WVNuV2hKNlRDYUU2WDNqV25mNlk3Z1lGWGpvQjk0dVB5alJ1LTVxejViakVHV2VEU0NMbUZDa0YzVHNUU2RLQUNsQW82SVlfZ3lmNDVqYXVuMUlTc2lnMHZu?oc=5","date":"2026-03-20","type":"pipeline","source":"CBS News","summary":"Nearly 90,000 bottles of children's ibuprofen recalled due to reports of foreign substances - CBS News","headline":"Nearly 90,000 bottles of children's ibuprofen recalled due to reports of foreign substances","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-26","type":"regulatory","source":"ET Pharma","summary":"Sun Pharma arm recalls over 17,000 units of antifungal shampoo in US: USFDA - ET Pharma","headline":"Sun Pharma arm recalls over 17,000 units of antifungal shampoo in US: USFDA","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-26","type":"pipeline","source":"Medical Dialogues","summary":"Sun Pharma unit Taro recalls over 17k units of antifungal medication in US - Medical Dialogues","headline":"Sun Pharma unit Taro recalls over 17k units of antifungal medication in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNU1I2YU8tZVlLWHlXNHBlNHNLTWVtOVFKWFR2WUxqeEJXbVVUM3NqTll6QVZxWTFRQnNQbFZGOVc5ajlsOEI1dXhqWU9Iay1JOFQ5bUNlb1BVM085azhGVnNZeENhT3VmbDQydUx4Ml9NQ05nSkxSSTJYcENnakROakxBVEcxM0hzZGY3cG5paUQxZ9IBnwFBVV95cUxOT3Uwcmptc3V2SlBPMmYzNTg2X19TOTNyaGp3MkVjb0IxZklQWnljeW5rSWVWODQzUlB4czlnLVF6N1RDaG9OdFBnNjZVT0YtR2VPb1dPcXZBaXRIRGVzanM2RDRuVVNrTWNUamhoWHFmQS1ocVUtRFJzSE81QmxxaENwUVlBNWJpU3h0cHlpWVpObjN5U09HX3NYSzd3azA?oc=5","date":"2025-12-26","type":"regulatory","source":"NewsGram","summary":"Sun Pharma’s Taro Recalls Over 17,000 Units of Antifungal Shampoo in US: FDA - NewsGram","headline":"Sun Pharma’s Taro Recalls Over 17,000 Units of Antifungal Shampoo in US: FDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNX3R2TnBqTThTYjQ2NmJGRkRsQ2dra3NoVFNOZW9aRUJLbmw5a3RSTTFVTGtya1hXWjJMNTZORmNDaDVFdnJqTTJMOUdBdkJXM0tfaHVDa3RPQjk0RlFwWkt0NEtZQmJwQjNRckU3TmRmX2JTb3R0Rk9kb1hvR0N1RHNjSlZpZy1WVWVucms0ZGxJUUxqN2lGTjNVQjdyNXlVSTBpcmlxbm1TR2dTNnlRckIwemEyVWpBUHdRd2h2WUpjdDBZYnh6MjEtQmc2T0ZrUGVQZWRxdE05QlhwdVE1RjRyLVZ6QQ?oc=5","date":"2025-12-25","type":"pipeline","source":"scanx.trade","summary":"Sun Pharma Unit Recalls Over 17,000 Units Of Antifungal Shampoo In US Due To Manufacturing Issues - scanx.trade","headline":"Sun Pharma Unit Recalls Over 17,000 Units Of Antifungal Shampoo In US Due To Manufacturing Issues","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNbHM0RlIyM1hpVnRGVTAtRDdqLXotZVV2WVRZN2Zqb050SDJDZU5NSGk5MnQ1enZjZmhuT2JYUUJlU1FEQ2thbndYY1pmcExnbDNkSFhqWGtCcWdTQUNYaDM3NXhfeUZTaU1vblRVNUIyOG03SWdCUlRBVWVWNVdCd2p5V011enNSU0YwR0EzcWpRWi16VXZLSmlIMTE4enR3SU9pSjJvRVBJeWViWVRmLUluSGFZa2JxWjk2dzNYRGhEb3UyYUFSSdIB1gFBVV95cUxPRUVxLWw4Mk5LZzNkMmZ0bGF6S21UZHp3QU9YblFaa2JuZGpYQ1FGdGdYcHNZRjRrWHNfR1RIRjR6Vy1sakNEeDJpM1N6RHRhM0tPTUJUcFF2OVpMaUd5M0Q5WkRGUzZSbTNYQnpDZkgwSjNQcmFTVGJvVU9uWXlKNVRZY2Nnb3lZXzhNSXk0NWlGUFNWUG83NUEzRUtOc1Jmd1NDS3VINGd2YkRoMXM3aUlxRTJjRk5iY1RlaFA2d2xVWWR1UDVXRHl3SnlwYWVoaWxveU93?oc=5","date":"2025-12-25","type":"pipeline","source":"The New Indian Express","summary":"Sun Pharma’s US arm pulls antifungal shampoo off shelves after quality lapse - The New Indian Express","headline":"Sun Pharma’s US arm pulls antifungal shampoo off shelves after quality lapse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNZUtYUXNKcWtwZGE3RmhXVmlESnRpcnhxeER5NzVpNE9jUkdzWm5LY3NfNWtXd1pZX2t1V1U4TDk5NDZfVHJvS1EzV1poaWlnY0J3QmpTQ1FjS3Q2NnJQa0NRbnRzRXB0WFR0THJ3X1lGbnE3MU8yZEdocHEwazc4LWZqUUxuYlVaQ05pcVVsRUFXbDR0ZjVDNjZkWk1pYUg1YU5v?oc=5","date":"2025-10-28","type":"deal","source":"Bloomberg Law News","summary":"Sun Pharma Defeats Taro Investor Suit Over Take-Private Deal - Bloomberg Law News","headline":"Sun Pharma Defeats Taro Investor Suit Over Take-Private Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPMjlnazlNUnRQMzU3SWRWZUpqa0JsbEViZFNCRXc4TGNONXdwRWYtUnlOaTQwcEZYSkJXT3ZPNlJHRUFtVF90MDc5aGFGYVVuSWVQN1M4RlNvSlVtTHYwNkJrcktUb0pqMkRBYnlEcU1kYzN1bEZ2eVZPdEZuaWFkYmhVRmVVdVNVZzhwWDZhQzJXcTd5NWJManNaUl9UXzhqMmhPUk1FcVZNUQ?oc=5","date":"2025-07-25","type":"patent","source":"Fierce Pharma","summary":"Sun Pharma, Taro agree to $200M settlement in generics price-fixing litigation - Fierce Pharma","headline":"Sun Pharma, Taro agree to $200M settlement in generics price-fixing litigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOejFRMXFCR1hsVVlPZkVHUkk4ZmVRRkl2LV8za01xdm1VUGRZc1BHRU42dEViTW5IbHNpSzIzdE9wX2NLVEl3R0tXa3lPZTNQWEVUQzR4ZFlwSF9MVlJ1V0dmUHM3b3JONlBpMWJya0I1YmhWZHVhc0g3ZG9wQjRYVnY1SXZodWpvbmhvMmM3N3lmSlpmaXJJY0w1UVZVMHprYVRRdVF3RTdZbFFkang3c0FB?oc=5","date":"2025-07-24","type":"patent","source":"bloomberg.com","summary":"Sun Pharma to Settle US Generics Pricing Case for $200 Million (SUNP) - bloomberg.com","headline":"Sun Pharma to Settle US Generics Pricing Case for $200 Million (SUNP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNQzVMTmhObW1kSUhJTGQ3Z1U4eTRuUV9fM1RyWnBpVWlXS2E4YjdQcGdCRGVweUVBLXhWeFJ4ellFbmU0NzBUd2VzcWZ1YnRDRXBHQk44ZkJ0dHV4c1VaM3hwU0dyMDNBTnByTUNpT0dSS1oxMGQ4d21FQ21fbWFjWjdlQ2YzSVVwczAxTXdKeExnZDlXUDNuLWNCbHBiNUxjc1Q4?oc=5","date":"2025-07-24","type":"pipeline","source":"pymnts.com","summary":"Sun Pharma to Pay $200 Million to Settle US Price-Fixing Allegations - pymnts.com","headline":"Sun Pharma to Pay $200 Million to Settle US Price-Fixing Allegations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQY0txSFFOYTFPRmdIWWQzMmdtM0FpYVpWcmY2ZlFGRHBFNkdsRkdrZGM5OU1vbS1EVUt2VFBBMDF1aTRsUEticUVtZDlNMXpwOUxKSWo4M2xtQ2JhRWJFalY1SFplaVVKbGwyaktNcUU1S3VwTTBkY08yT0EzanNtcE94R0NnOXdEU1o5anNNZVltUk5kSGFnbVBQVGtGSThsTHVhZjd3?oc=5","date":"2024-01-17","type":"deal","source":"PR Newswire","summary":"Taro Announces Merger Agreement with Sun Pharma - PR Newswire","headline":"Taro Announces Merger Agreement with Sun Pharma","sentiment":"neutral"}],"patents":[{"drugName":"Triamcinolone Acetonide Cream USP, 0.1%","drugSlug":"triamcinolone-acetonide","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000},{"drugName":"Topicort","drugSlug":"desoximetasone","patentNumber":"8715624","type":"Formulation","expiryDate":"2026-05-26","territory":"US","genericFilings":[]},{"drugName":"Clobetasol Propionate Cream, 0.05%","drugSlug":"clobetasol-propionate","patentNumber":"","type":"Patent Cliff","expiryDate":"2027-06-01","territory":"US","annualRevenue":50000000},{"drugName":"Topicort","drugSlug":"desoximetasone","patentNumber":"8277780","type":"Formulation","expiryDate":"2028-09-01","territory":"US","genericFilings":[]}],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sandoz","Mylan","Endo International"],"therapeuticFocus":["Dermatology","Specialty Pharmaceuticals"],"financials":null,"yahoo":null}